28 April, 2022 in Featured HealthCare, Healthcare, Pri Press Releases, Study / 0 Comments NEW BRIEF: Broken System Imposes Higher Out-of-Pocket Costs on Patients, Puts Interests of Government and Insurers First
21 March, 2022 in Commentary, Environment / 0 Comments States and Municipal Lawsuits Undermine Innovative Climate Solutions
10 February, 2022 in Business Economics, Commentary / 0 Comments The Empty Case for Stakeholder Capitalism and ESG Investing
16 January, 2022 in Business Economics, Commentary, Featured Business Economics / 0 Comments Controlling Inflation Requires A Better Policy Mix, Not Business Scapegoating
12 January, 2022 in Featured HealthCare, Healthcare, Study / 0 Comments NEW BRIEF: The Fundamental Flaws of the Third-Party Payer System
10 November, 2021 in Featured HealthCare, Featured Homebox1, Healthcare, Pri Press Releases, Study / 0 Comments NEW BRIEF: 340B Hospitals More Profitable, Provide Less Charity Care, Receive Unwarranted Subsidies
03 November, 2021 in Healthcare, Study / 0 Comments NEW BRIEF: U.S. Patients Could Save Up to $5.8 Billion Through Competition from Humira and Enbrel Biosimilars
21 October, 2021 in Featured HealthCare, Featured Homebox1, Healthcare, Pri Press Releases, Study / 0 Comments New PRI Series to Show How Flawed U.S. Health Insurance System Inflates Costs, Decreases Quality and Reduces Health Outcomes
03 August, 2021 in Featured HealthCare, Featured HomeBox2, Healthcare, Study / 0 Comments NEW STUDY: Creating Two-Part Drug Pricing System Would Ensure Prices More Accurately Reflect How Patients
17 March, 2021 in Healthcare, Study / 0 Comments ISSUE BRIEF: ICER Analyses Are Flawed, Undervalue Life-Saving Medicines, and Are Biased Toward Price Controls
